The Quantellect read.As of Nov 19, 2026, 6 active firms cover Community Health Systems Inc: 1 rate it Buy or better, 3 sit at Neutral, and 2 rate it Sell or worse, a neutral consensus. Targets range widely, $2.00 to $4.00 (about 2.0x), a sign of real disagreement on valuation. The average target of $2.96 sits 60% above the current $1.85. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.32 next quarter toward $-0.79 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 active firms
Neutral
Strong Buy00%
Buy117%
Neutral350%
Sell233%
Strong Sell00%
Based on 6 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$2.96
+59.9% upside
Average target across 6 active firms as of Nov 19, 2026 vs $1.85 current
Highest Target$4.00
Average Target$2.96
Lowest Target$2.00
Detailed analyst forecasts for CYH
Showing 1–6 of 6 named analysts shown · 6 active firms in the rating projection
As of Nov 19, 2026, 1 of 6 active firms rate CYH a Buy (3 Neutral, 2 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
CYH EPS & revenue forecast
EPS · NEXT QUARTER
$-0.32
Range $-0.39 – $-0.26 · 3 analysts · -34% YoY
Next period, 3 analysts expect Community Health Systems Inc to earn $-0.32 a share (range $-0.39 – $-0.26), versus $-0.48 a year earlier. Full-year consensus is $-1.37, growing to $-0.79 the year after.
REVENUE · NEXT QUARTER
$2.7B
Range $2.7B – $2.8B · 3 analysts · -7% YoY
Revenue is expected to reach $2.7B (range $2.7B – $2.8B), -7.5% year-over-year. Full-year consensus is $11.4B, rising to $11.3B next year.
Top analysts covering Community Health Systems Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CYH.
#1
Stephen Baxter
Wells Fargo · Rank #63
Sell
$2.00+8.1% to target
Overall win rate
47%
+ Follow
#2
DM
David Macdonald
Truist Securities · Rank #111
Neutral
$3.25+75.7% to target
Overall win rate
50%
+ Follow
#3
Ben Hendrix
RBC Capital · Rank #150
Buy
$4.00+116.2% to target
Overall win rate
44%
+ Follow
#4
Brian Tanquilut
Jefferies · Rank #280
Neutral
$3.00+62.2% to target
Overall win rate
46%
+ Follow
#5
AR
A.J. Rice
UBS · Rank #365
Neutral
$3.00+62.2% to target
Overall win rate
35%
+ Follow
CYH stock forecast FAQ
What is CYH's average 12-month price target?+
The 6 active firms with a live target average $2.96 for Community Health Systems Inc over the next 12 months, ranging from a $4.00 high to a $2.00 low, as of Nov 19, 2026.
Is CYH stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 6 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 3 rate it Neutral, and 2 rate it Sell or Strong Sell.
What are the highest and lowest price targets for CYH?+
The Street-high target is $4.00 (RBC Capital), and the Street-low is $2.00 (Wells Fargo). The average of all 6 active-firm targets is $2.96.
How many active Wall Street firms cover CYH?+
6 active firms have a recognized rating on Community Health Systems Inc as of Nov 19, 2026, and 6 active firms carry a live 12-month price target.
Who is the most accurate analyst covering CYH?+
Among analysts who currently cover CYH, Stephen Baxter of Wells Fargo has the strongest overall Quantellect track record (Rank #63). Their current call is Sell with a $2.00 target.
What is Community Health Systems Inc's projected EPS for next quarter?+
The consensus estimate is $-0.32 per share (range $-0.39 – $-0.26) across 3 analysts. Full-year EPS is projected at $-1.37, rising to $-0.79 the following year.
How much revenue is Community Health Systems Inc expected to report next quarter?+
Consensus revenue is $2.7B (range $2.7B – $2.8B). Full-year revenue is projected at $11.4B, growing to $11.3B next year.
Have analysts been upgrading or downgrading CYH lately?+
As of Nov 19, 2026, 1 of 6 active firms rate CYH a Buy (3 Neutral, 2 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CYH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.